Evaluation of combined biomarkers for tumor response to immunotherapy (I/O) in patients with advanced non-small cell lung cancer (NSCLC)

H. Ramdani, M. Falk, S. Schatz, M. Tiemann, L. C. Heukamp, E. Schuuring, H. J. Groen, F. Griesinger

Onderzoeksoutput: Meeting AbstractAcademic

Originele taal-2English
Pagina's (van-tot)77-77
Aantal pagina's1
TijdschriftOncology Research and Treatment
StatusPublished - 2019

Citeer dit